NEW YORK (GenomeWeb News) – The biotechnology entrepreneur Alejandro Zaffaroni, who co-founded Affymetrix, has died at the age of 91, The New York Times has reported.

Originally from Uruguay, Zaffaroni helped to launch biotechnology and Silicon Valley companies beyond Affymetrix, including Alza, Syntex, Perlegen Sciences, Symyx Technologies, DNAX, and Maxygen. He also had a hand in bringing new technologies to market, including Affymetrix's biochips, as well as the birth control pill and the nicotine patch.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.